日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Pongo abelii E3 ubiquitin-protein ligase RNF128 (RNF128), partial CSB-YP713027PYX1
CSB-EP713027PYX1
CSB-BP713027PYX1
CSB-MP713027PYX1
CSB-EP713027PYX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Signal peptidase complex subunit 1 (SPCS1), partial CSB-YP713028PYX1
CSB-EP713028PYX1
CSB-BP713028PYX1
CSB-MP713028PYX1
CSB-EP713028PYX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Fructose-bisphosphate aldolase B (ALDOB) CSB-YP713029PYX
CSB-EP713029PYX
CSB-BP713029PYX
CSB-MP713029PYX
CSB-EP713029PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (RPN1), partial CSB-YP713030PYX
CSB-EP713030PYX
CSB-BP713030PYX
CSB-MP713030PYX
CSB-EP713030PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Zinc transporter SLC39A7 (SLC39A7), partial CSB-YP713031PYX1
CSB-EP713031PYX1
CSB-BP713031PYX1
CSB-MP713031PYX1
CSB-EP713031PYX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Chitinase domain-containing protein 1 (CHID1) CSB-YP713032PYX
CSB-EP713032PYX
CSB-BP713032PYX
CSB-MP713032PYX
CSB-EP713032PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii 60S ribosomal protein L41 (RPL41) CSB-YP713033PYX
CSB-EP713033PYX
CSB-BP713033PYX
CSB-MP713033PYX
CSB-EP713033PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Ras-related protein Rab-28 (RAB28) CSB-YP713034PYX
CSB-EP713034PYX
CSB-BP713034PYX
CSB-MP713034PYX
CSB-EP713034PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Interleukin enhancer-binding factor 2 (ILF2) CSB-YP713035PYX
CSB-EP713035PYX
CSB-BP713035PYX
CSB-MP713035PYX
CSB-EP713035PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Electron transfer flavoprotein subunit beta (ETFB) CSB-YP713036PYX
CSB-EP713036PYX
CSB-BP713036PYX
CSB-MP713036PYX
CSB-EP713036PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii tRNA (uracil (54)-C (5))-methyltransferase homolog (TRMT2B) CSB-YP713037PYX
CSB-EP713037PYX
CSB-BP713037PYX
CSB-MP713037PYX
CSB-EP713037PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Cyclin-D1-binding protein 1 (CCNDBP1) CSB-YP713038PYX
CSB-EP713038PYX
CSB-BP713038PYX
CSB-MP713038PYX
CSB-EP713038PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Glycine N-acyltransferase (GLYAT) CSB-YP713039PYX
CSB-EP713039PYX
CSB-BP713039PYX
CSB-MP713039PYX
CSB-EP713039PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo abelii Periodic tryptophan protein 2 homolog (PWP2), partial CSB-YP713040PYX
CSB-EP713040PYX
CSB-BP713040PYX
CSB-MP713040PYX
CSB-EP713040PYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Scavenger receptor class A member 5 (scara5), partial CSB-YP713041DIL
CSB-EP713041DIL
CSB-BP713041DIL
CSB-MP713041DIL
CSB-EP713041DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Meiosis expressed gene 1 protein homolog (meig1) CSB-YP713042DIL
CSB-EP713042DIL
CSB-BP713042DIL
CSB-MP713042DIL
CSB-EP713042DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Condensin-2 complex subunit H2 (ncaph2), partial CSB-YP713043DIL
CSB-EP713043DIL
CSB-BP713043DIL
CSB-MP713043DIL
CSB-EP713043DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio LYR motif-containing protein 2 (lyrm2) CSB-YP713044DIL
CSB-EP713044DIL
CSB-BP713044DIL
CSB-MP713044DIL
CSB-EP713044DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Class A basic helix-loop-helix protein 9 (Bhlha9) CSB-YP713045MO
CSB-EP713045MO
CSB-BP713045MO
CSB-MP713045MO
CSB-EP713045MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Cadherin-12 (Cdh12), partial CSB-YP713046MO
CSB-EP713046MO
CSB-BP713046MO
CSB-MP713046MO
CSB-EP713046MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×